Press release
Live Biotherapeutic Product (LBP) Market Current Scenario with Future Aspect Analysis
The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 79.89 Million in 2022 and is predicted to reach 1077.17 Million by the year 2031 at a 28.9 % CAGR during the forecast period for 2023-2031.
Get A Free Report Sample Brochure: https://www.insightaceanalytic.com/request-sample/1152
Live Biotherapeutics are a recognized new class of medicines which contains live organisms, such as bacteria. These live microbiome drugs can prevent, treat and cure the disease conditions of humans and potentially transform how we treat many diseases. These therapeutics do not contain any vaccine category. These microbes produce and consume numerous compounds that considerably impact our health and well-being. The reintroduction of beneficial microorganisms has the potential to act as clinically relevant therapies to re-establish and maintain a healthy microbiome. Importantly, LBPs will also have a biological impact by affecting the local ecosystem, other microbes, and their interactions with the host.
Over the forecast period, market growth is anticipated to be driven by expanding research and development efforts as well as a growing pipeline of microbiome-targeting therapies that are anticipated to treat a wide range of serious diseases. The market is developing due to increasing innovation and technological developments in developing new pharmaceuticals and clinical trial activities for illness treatment. During the forecast period, significant growth opportunities are anticipated due to rising government funding and an increased R&D budget for drug development. Over 640 patents focused on microbiome therapeutics were approved in during last 2 years.
Challenges related to ensuring com
pliance with good manufacturing practices (GMP), Associated Safety Issues with LBPs and capacity include limited availability of expertise, a lack of specialized infrastructure which need for excessive capital investment, and the requirement for high capital expenditure. These factors are expected to restrain the growth of the market. However, due to rising demand for new novel drugs and the significant burden of bacterial infection disease, North America is expected to experience rapid growth during the forecast period (2022-2030). Companies receive enormous funding for product development and research on Live Biotherapeutic ingredients.
The key players involved in live biotherapeutic products industry are Seres Therapeutics, Inc., Microbiotica, Enterome, Destiny Pharma plc, Taisho Pharmaceutical Holdings, AOBiome Therapeutics, Inc., Finch Therapeutics Group, Inc, Ferring Pharmaceuticals, Rebiotix Inc. (A Subsidiary of Ferring Pharmaceuticals), MaaT Pharma, Vedanta Biosciences Inc., OxThera AB, Pendulum Therapeutics, Caelus Health, Quorum Innovations, Sanofi S.A, DermBiont, Inc., EnteroBiotix Ltd, YSOPIA Bioscience, Winclove Probiotics, TargEDys, Evelo Biosciences, Inc., BiomX, Biomica Ltd., Scioto Biosciences, Inc., Lactobio A/S, Takeda Pharmaceutical Co. Ltd., Second Genome Therapeutics, Johnson and Johnson Inc., Kaleido Biosciences Inc., OptiBiotix Health Plc, PureTech Health Plc, Immuron Limited, Naked Biome, Synthetic Biologics, ExeGi Pharma, Nexbiome, Mybiotics Pharma LTD, 4D pharma plc, Axial Therapeutics, Inc., BrickBuilt Therapeutics, Siolta Therapeutics, Stellate Therapeutics, Sciotio Biosciences Inc, Rise Therapeutics, EverImmune S.A. and others.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1152
Key developments in the market:
• In Mar 2022, Microbiotica has accomplished a £50 million ($67 million) Series B financing round, the largest microbiome-related financing round in Europe to date. The assets will also be used to advance Microbiotica's two lead oral Live Bacterial Therapeutics (LBTs), MB097 and MB310, to Phase 1b clinical trials, as well as LBTs in new disease areas.
• In Nov 2021, Together by collaboration, Bacthera and Seres Therapeutics will commercially manufacture SER-109, a possible cure for recurrent C. difficile infection. According to the terms of the contract, Bacthera will build a special facility for commercial production in its new facility Microbiome Center of Excellence on Lonza's Ibex campus in Visp, Switzerland that is devoted to the production of LBPs.
• In Aug 2021, Finch Therapeutics announced that the development of the FIN-524 Ulcerative Colitis Program will be accelerated its strategic partner Takeda. Prior to the anticipated start of clinical-stage development, Takeda will take over primary development responsibility for the programme, which is now known as TAK-524. With the change, Takeda will be able to use its knowledge of inflammatory bowel disease (IBD) for the duration of the clinical development of FIN-524/TAK-524.
• In Nov 2020, ExeGi Pharma declares EXE-346 Live Biotherapeutic an FDA orphan drug. Drugs and biological products designed to treat diseases that affect fewer than 200,000 patients in the US are given some advantages thanks to this designation. An LBP called EXE-346 has a fixed-proportion of 8 live probiotic bacterial strains that are meant to be taken orally.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1152
Market Segmentation
Global Live Biotherapeutic Product (LBP) Market, by Type Of Product, 2022-2030 (Value US$ Mn)
• Probiotic Drugs
• Other Drugs
Global Live Biotherapeutic Product (LBP) Market, by Type of Molecule, 2022-2030 (Value US$ Mn)
• Small Molecules
• Biologics
Global Live Biotherapeutic Product (LBP) Market, by Target disease indication, 2022-2030 (Value US$ Mn)
• Graft Versus Host Disease
• Necrotizing Enterocolitis
• Primary Hyperoxaluria,
• Recurrent C. difficile Infection
• Others
Global Live Biotherapeutic Product (LBP) Market, by Therapeutic area, 2022-2030 (Value US$ Mn)
• Digestive and Gastrointestinal Disorders
• Infectious Diseases
• Rare Disorders
• Others
Global Live Biotherapeutic Product (LBP) Market, by Route of administration, 2022-2030 (Value US$ Mn)
• Oral Therapeutics
• Rectal Therapeutics
Global Live Biotherapeutic Product (LBP) Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Live Biotherapeutic Product (LBP) Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Live Biotherapeutic Product (LBP) Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Live Biotherapeutic Product (LBP) Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Live Biotherapeutic Product (LBP) Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Live Biotherapeutic Product (LBP) Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
For More Information: https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
Why should buy this report:
To receive a comprehensive analysis of the pipeline products prospects for the Live Biotherapeutic Product (LBP) Market
To receive an industry overview and future trends of the Live Biotherapeutic Product (LBP) Market
To analyze the Global Live Biotherapeutic Product (LBP) Market drivers and challenges
To get information on the Global Live Biotherapeutic Product (LBP) Market size (Value US$ Mn) forecast to 2030
To get information on investments, mergers & acquisitions in the Global Live Biotherapeutic Product (LBP) Market industry
Other Related Reports Published by InsightAce Analytic:
Global Live Biotherapeutic Products And Microbiome Contract Manufacturing Market
Global Human Microbiome-based Gut Health Test and Nutrition Market
Global Animal Microbiome Market
Global Microbiome in Skincare Market
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Live Biotherapeutic Product (LBP) Market Current Scenario with Future Aspect Analysis here
News-ID: 3279992 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Mar
Consumer Adoption Of Smartphones And Tablets Fuels The Mobile Augmented Reality …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Mobile Augmented Reality (MAR) Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size of mobile augmented reality (MAR) has been expanding dramatically. The market is projected to increase from $27.57 billion in 2024 to $37.19 billion in 2025, with a compound annual growth…
1 New Article from Happy Smoking - MAR 2025
Happy Smoking is your definitive guide to smoking culture, providing expert reviews, comprehensive guides, and a platform for aficionados to connect and share their passion. We offer responsible, accurate information on enjoying cigars, pipes, and hookahs
.
Austin, TX - MAR 2025: Happy Smoking, a leader in smoking guides and expert reviews, is thrilled to announce the publishing of 1 new article on our platform. This month's update includes a diverse range…
Bungalows Del Mar Office by Harbor Associates in Del Mar, California Defies Nati …
Image: https://www.abnewswire.com/upload/2025/01/5bf83fc4238a3b3089be31e9b2ba64df.jpg
Seal Beach, CA - January 17, 2025 - Harbor Associates, LLC ("Harbor"), a value add and opportunistic buyer and owner in the office market, completed the lease up of the Bungalows Del Mar Office (https://www.thebungalowsdelmar.com/) despite the pandemic and work from home trends and now the recession that has slowed traditional office leasing. This Del Mar office space created by Harbor has been so successful that a rare…
Sport Sunglasses Market is Booming Worldwide | Oakley, Tifosi, Costa Del Mar
A Latest intelligence report published by AMA Research with title "Global Sport Sunglasses Market Outlook to 2028. A detailed study accumulated to offer Latest insights about acute features of the Sport Sunglasses market. This report provides a detailed overview of key factors in the Global Sport Sunglasses Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development.
Definition:
Sport sunglasses are specialized eyewear designed to…
Mobile Augmented Reality (MAR) Market 2021 | Detailed Report
The Mobile Augmented Reality (MAR) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the…
Casa Del Mar - Bronx's Exquisite Bar and Restaurant
Bronx, New York City, Release: March 19, 2020
Seafood Dining at Its Best
Are you on a seafood diet?
If you are on a seafood diet, then what's better than sitting at Casa Del Mar, get hooked on seafood at a beautiful restaurant located in the heart of the Bronx that features the most exquisite seafood cuisine of all times.
Established on, the restaurant is an ideal seafood destination for all the gastronomes and…
